CLOSE

Quant Healthcare Fund-Reg(G)

very highequitypharma & health care
17.01 -0.36(-2.05%) NAV as on 19 Sep 2024
2.74 % 1 M
55.93 % 1 Y
NA 3 Y

Growth Chart of the Scheme vis a vis benchmark

  • 1W
  • 1M
  • 3M
  • 6M
  • 1Y
  • 3Y
  • 5Y
  • 10Y

SCHEME DETAILS

Expenses Ratio :

2.37

As on 31 Aug, 2024
Age :

1 yrs 2 m

Since 17 07 ,2023
Exit Load :

1%

AUM :

431.52 Crs

Portfolio Price To Book Value :

6.69

Investing Style :

Mid Growth

Min. Investment :

SIP 1000 & Lumpsum 5000

Category :

sector funds

Fund Manager :

Sandeep Tandon,Ankit Pande,Sanjeev Sharma

Launch Date :

17-Jul-23

Scheme Benchmark :

NA

FUND OBJECTIVE

The investment objective of the scheme is to seek long term capital appreciation by investing in equity/equity related instruments of companies from the healthcare sector. However, there is no assurance or guarantee that the investment objective of the Scheme will be achieved.

RISKOMETER Level of Risk in the Scheme

Investors understand that their principal will be at very high risk

LATEST ASSET & PORTFOLIO ALLOCATION

as on Aug 31 ,2024
Others 11.73 %
Equity 88.27 %

TOP HOLDINGS

HFCL Ltd.8.29 %
Pfizer Ltd.8.06 %
Aurobindo Pharma Ltd.7.90 %
Dr. Reddy's Laboratories Ltd.7.19 %
Zydus Wellness Ltd.6.83 %

ALLOCATION BY MARKET CAP

ALLOCATION BY SECTOR

Pharmaceuticals & Drugs66.72
Telecom-Infrastructure8.29
Consumer Food6.83
Hospital & Healthcare Services5.75
Trading0.69

5-YEARS HISTORY

Financial Year2023-2024
NAV in Rs (as on 31-Mar-2024)13.12
Net Assets(Rs Crores) (as on 31-Mar-2024) 264.51
Scheme Returns(%)(Absolute)31.20
B'mark Returns(%)(Absolute)NA
Category Rank54/90

Quarterly Performance - Last 5 Years (Absolute Ret. In %)

Financial Year Q1 Q2 Q3 Q4
2024-202511.82NANANA
2023-2024NANA13.487.78

PERFORMANCE COMPARISON WITH SIMILAR SCHEMES

Quant Healthcare Fund-Reg(G)Very HighEquity17.01-0.36(-2.05%)NAV As on 19 Sep, 202417-Jul-2023Inception Date431.52AUM In Cr.55.93%1YNA%3YNA%5Y57.01%Since Inception

Mutual fund and other investments are always subject to market risks. Please read all, Scheme Information Documents (SID), Key Information Memorandum (KIM), Addendums(if any) issued there to from time to time and any other related documents or information carefully before investing. Past performance is not indicative or assurance of future performance or returns. Please consider your specific investment requirements before choosing a fund.

For any grievances, investors can contact at: hello@benchmarkinvestments.in,  Tel: +91-755-4938282 / +91-9826310337.
©  Copyrights 2022 , Benchmark Investments | All Rights Reserved |  Designed, Developed & Content Powered by Accord Fintech Pvt Ltd